StockGlow

Helix BioPharma Corp. (HBP.TO)

Develops antibody treatments to shrink solid tumors and improve cancer immunotherapy effectiveness.

1.45+0.01%Healthcare
Compare HBP.TO with
StockGlow Score
7
Bearish
BearishBullish
1 year ago+34.3%

The outlook

Helix BioPharma is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, reflecting a downtrend. Analyst coverage appears minimal, and the overall sentiment leans bearish. The stock remains depressed relative to recent price levels.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Market cap
$110.7M
52-wk high
5.40
52-wk low
0.95
50-day avg
1.49
200-day avg
1.92
Trailing P/E
—

Similar stocks

MBX.TOMicrobix Biosystems Inc.$0.31+0.00%EDT.TOSpectral Medical Inc.$1.37-0.72%RVX.TOResverlogix Corp.$0.10-4.76%MDNA.TOMedicenna Therapeutics Corp.$0.36+2.90%FRX.TOFennec Pharmaceuticals Inc.$13.95-4.78%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy